knw,
Hard to pick BUT..
..per Merrill's initiating coverage in early Nov 2011 the global mkt for CHF is $57bn which is only second to Diabetes($259bn).
The 3rd largest application in MSB's pipeline is Intervertebral Discs - Global mkt for this application is huge ($42bn)
On this point I noticed that on Page 6 of the report the 100 Patient Phase II Disk Trials have COMPLETED enrollment.
..."Mesoblast’s doubleblind,placebo-controlled Phase 2 clinical trial conducted across 15 sites in the United States has just completed enrollment of the full 100 patients with intervertebral disc disease"...
This trial started in Augst 11 and fully enrolled on just over 12 months...which helps explain the recent addition to staff in the orthepidics field..In my view this rapid recruitement is extraordinary and will not go unobserved by Big Phanrma medical device companies.
Yes - looking forward to AGM.
DYOR as above are my views only.
knw,Hard to pick BUT....per Merrill's initiating coverage in...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |